Ethical Considerations of Hydroxychloroquine During the COVID-19 Pandemic
Main Author: | Amy Reese |
---|---|
Format: | Article |
Language: | English |
Published: |
California Pharmacists Association
2021-08-01
|
Series: | Journal of Contemporary Pharmacy Practice |
Online Access: | https://meridian.allenpress.com/jcphp/article/68/2/7/468982/Ethical-Considerations-of-Hydroxychloroquine |
Similar Items
-
Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
by: Katja Voit, et al.
Published: (2021-05-01) -
Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19
by: Vasilios M. Polymeropoulos
Published: (2020-04-01) -
Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic
by: Dauner, D.G, et al.
Published: (2021) -
Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
by: Partha Sarathi Biswas, et al.
Published: (2020-09-01) -
Hydroxychloroquine, COVID-19, and prophylaxis
by: Viroj Wiwanitkit
Published: (2020-01-01)